Of the 52 new drugs approved in the past decade, 21% were categorized as first in class, but more innovations are needed for skin diseases with unmet therapeutic needs, the authors said.
Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly.
The U.S. health regulator s staff on Wednesday flagged concerns that data on Merck s chronic cough drug might not be enough to prove the treatment s meaningful benefit.
/PRNewswire/ The "Liquid Handling: Technologies and Global Markets" report has been added to ResearchAndMarkets.com s offering. This report will focus on.